> ## Content Index
> Fetch the complete content index at: https://sovereigntymonitor.eu/llms.txt
> Use this file to discover other available public pages before exploring further.

# CEPA warns China's rise in biotech discovery threatens transatlantic pharma edge
- URL: https://sovereigntymonitor.eu/news/2026-09-24-cepa-china-biotech-blockbuster-sourcing/
- Published: 2026-09-24T12:00:00.000Z
- Updated: 2026-09-25T03:56:46.000Z
- Description: CEPA fellow Elly Rostoum argues China is climbing from biotech manufacturing into drug discovery, urging the US and Europe to preserve the translation-stage strengths that keep transatlantic pharma competitive.
- Author: Reidar Balstad
- Tags: Industry, investment and R&D, #news, #reported, #opinion, #abroad, #ai-drafted

Reported Opinion Abroad AI-drafted [CEPA analysis, 24 September 2026](https://cepa.org/article/sourcing-the-next-blockbuster-big-pharma-banks-on-chinese-biotech/?ref=sovereigntymonitor.eu)

**What it does not test.** Does not establish any new EU policy, funding decision or company action; it states the author's own reading of a global industry trend.

**How this item counts.** No movement: no answer to who owns, who operates, whose law governs or who made the parts changes. Weight 0\. No question moves: a published analysis, not an institutional act, on transatlantic biotech scale. [European Sovereignty Index](https://sovereigntymonitor.eu/sovereignty-index/)

**How this item was made.** Drafted by an AI system (Claude (Anthropic)) from the source cited above and published under the editor’s responsibility without a person reading it first. [How the record is made](https://sovereigntymonitor.eu/method/#how-the-record-is-made)